SBIR/STTR Research Award

M.pneumoniae Detection by Fluorescence Measurement

Award identifier 672cdd3cd90443dfb12d42aeb4043b2e411c48a25e91455e3b8d2108e25856c9Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,997

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MICROGEN, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Mycoplasma pneumoniae, a human pathogen, primarily causes pneumonia and various other respiratory infections and contributes significantly to worldwide morbidity and mortality. The clinical features associated with M. pneumoniae are often indistinguishable from a variety of other viral and atypical bacterial pathogens, and infections tend to be quite chronic and transmit fast in community-populations. Rapid detection of the microbial agent with high sensitivity and specificity is critical for appropriate treatment and control of disease transmission. The specific focus of this project is to develop a rapid detection method that requires fewer steps to completion, is simple to adopt in a clinical setting, and yet will provide high sensitivity and specificity. The method will be based on single-step amplification of a gene specific of M. pneuminiae in the presence of a stem-loop structured fluorescent energy transfer probe. The amplification will be by a DNA polymerase potentially insensitive to specimen-inhibitor so as to reduce the limitation as applied in clinical samples. The probe will be designed to hybridize specifically with its target; and only upon probe-target hybrid formation, fluorescence will be emitted from a reporter fluorophore attached to it. The presence of M. pneumoniae will be detected by fluorescence measurement of a post-nucleic acid amplified sample immediately after amplification, thereby requiring no additional steps. The method will also be tested in prototype strains and clinical isolates of M. pneumoniae to examine the feasibility of applying it in actual specimens to be tested in Phase II.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.